News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Duke Cancer Institute Study


6/17/2013 7:11:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study. The findings, presented June 15, 2013, at the annual Endocrine Society meeting in San Francisco, indicate that the drug bazedoxifene packs a powerful one-two punch that not only prevents estrogen from fueling breast cancer cell growth, but also flags the estrogen receptor for destruction.

Hey, check out all the research scientist jobs. Post your resume today!

Read at EurekAlert!
Read at ScienceDaily
Read at Medical News Today

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES